According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...
Accurate RNA splicing is essential for gene expression and human health, yet predicting how DNA sequence variations affect ...
The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...
By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing ...
Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist ...
RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
Closing the rare disease diagnostic gap can improve patient care and outcomes. Did you know that one in 10 Americans have a ...